Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...
OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Staff at Salt Lake City-based techbio company Recursion recently heard from Jenny and Tim Jones about their challenging ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
New research exposes how prompt injection in AI agent frameworks can lead to remote code execution. Learn how these ...
Databases are used in many different settings, for different purposes. For example, libraries use databases to keep track of which books are available and which are out on loan. Schools may use ...